198 related articles for article (PubMed ID: 8970874)
1. Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents.
Puttagunta NR; Gibby WA; Smith GT
Invest Radiol; 1996 Dec; 31(12):739-42. PubMed ID: 8970874
[TBL] [Abstract][Full Text] [Related]
2. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
Puttagunta NR; Gibby WA; Puttagunta VL
Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
[TBL] [Abstract][Full Text] [Related]
3. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K
Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
Tweedle MF; Wedeking P; Kumar K
Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy.
Gibby WA; Gibby KA; Gibby WA
Invest Radiol; 2004 Mar; 39(3):138-42. PubMed ID: 15076005
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme.
Corot C; Idee JM; Hentsch AM; Santus R; Mallet C; Goulas V; Bonnemain B; Meyer D
J Magn Reson Imaging; 1998; 8(3):695-702. PubMed ID: 9626889
[TBL] [Abstract][Full Text] [Related]
8. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation.
Idée JM; Berthommier C; Goulas V; Corot C; Santus R; Hermine C; Schaefer M; Bonnemain B
Biometals; 1998 Apr; 11(2):113-23. PubMed ID: 9542065
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
[TBL] [Abstract][Full Text] [Related]
11. Detectability of small liver metastases with gadolinium BOPTA.
Runge VM; Lee C; Williams NM
Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044
[TBL] [Abstract][Full Text] [Related]
12. The question of dose for gadolinium chelates in magnetic resonance imaging.
Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
Invest Radiol; 1994 Jun; 29 Suppl 2():S154-6. PubMed ID: 7928215
[No Abstract] [Full Text] [Related]
13. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
Andersen C; Taagehøj JF; Mühler A; Rehling M
Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189
[TBL] [Abstract][Full Text] [Related]
14. Impact of Treatment With Chelating Agents Depends on the Stability of Administered GBCAs: A Comparative Study in Rats.
Boyken J; Frenzel T; Lohrke J; Jost G; Schütz G; Pietsch H
Invest Radiol; 2019 Feb; 54(2):76-82. PubMed ID: 30358694
[TBL] [Abstract][Full Text] [Related]
15. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
Runge VM; Wells JW; Williams NM
Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
[TBL] [Abstract][Full Text] [Related]
17. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
Benness G; Khangure M; Morris I; Warwick A; Burrows P
Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
[TBL] [Abstract][Full Text] [Related]
18. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Nilsson S
Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
[TBL] [Abstract][Full Text] [Related]
20. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
Idée JM; Port M; Raynal I; Schaefer M; Le Greneur S; Corot C
Fundam Clin Pharmacol; 2006 Dec; 20(6):563-76. PubMed ID: 17109649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]